Lexicon gets Nasdaq 180-day extension to regain $1 bid; stock moves to Capital Market

LEXICON PHARMACEUTICALS, INC.

Nasdaq granted additional 180-day period until Dec 30, 2025 for Lexicon to cure $1 bid price deficiency.
Common stock will transfer from Nasdaq Global Select to Capital Market on July 7, 2025.
Compliance requires closing bid ≥ $1 for ten consecutive business days during the extension period.
Eligibility conditioned on meeting other listing requirements and intent to pursue reverse stock split if necessary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.